Filing Details
- Accession Number:
- 0000905718-14-000625
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-03 09:07:51
- Reporting Period:
- 2012-05-08
- Filing Date:
- 2014-10-03
- Accepted Time:
- 2014-10-03 09:07:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070698 | Raptor Pharmaceutical Corp | RPTP | Pharmaceutical Preparations (2834) | 860883978 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1614443 | Portfolio Segregated Trading Hyperion | C/O Tmf Ltd. Grand Pavillion Comm. Ctr 2Nd Fl., 802 West Bay Road, Po Box 10338 Grand Cayman E9 KY1-1003 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2012-05-08 | 11,700 | $5.56 | 4,897,287 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2012-05-09 | 6,500 | $5.64 | 4,890,787 | No | 4 | S | Direct | |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2012-06-01 | 3,000 | $5.22 | 4,893,787 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2012-06-04 | 2,000 | $5.20 | 4,895,787 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2012-06-12 | 8,000 | $5.35 | 4,903,787 | No | 4 | P | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2012-06-13 | 2,400,000 | $5.44 | 2,503,787 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | S | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | S | Direct |
Footnotes
- The shares of common stock, $0.001 par value per share (the "Common Shares"), of Raptor Pharmaceutical Corp., a Delaware corporation (the "Company"), reported herein were held by Hyperion Trading Segregated Portfolio (the "Reporting Person"), a segregated portfolio of Strategic Investment Tribes Fund SPC, a Cayman Islands exempted company registered as a segregated portfolio company, managed by Star Arrow Funds Expertise Ltd, a company organized under the laws of Anguilla ("Star").
- This price represents the weighted average purchase price of the Common Shares on May 8, 2012, which were purchased in multiple transactions ranging from $5.55 to $5.56, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the Staff of the Securities and Exchange Commission, upon request, the full information regarding the number of Common Shares bought at each separate price within the ranges set forth in this Form 4.
Billionaire Hedge Funds
